Negative outcomes associated with medication and adverse drug reactions in the emergency department. Real-life exploratory study
DOI:
https://doi.org/10.30827/ars.v64i3.27677Keywords:
pharmaceutical services, medication review, adverse drug reactions, emergenciesAbstract
Introduction. The aim of the study is to determine the prevalence of negative outcomes associated with medication (NOMs) and adverse drug reactions (ADRs) occurring in the emergency department (ED) of a health centre.
Method. An exploratory observational, cross-sectional study of patients with NOMs consulting in an ED. According to the variables of interest, the information was collected with an instrument designed and evaluated for this purpose.
A multivariate logistic regression model was applied to the NOMs and found the most important variables predisposing to the appearance of NOM. In addition, the avoid ability of NOM (Baena et al. criteria), the severity of NOM (Schneider classification) and the causality of ADR (Naranjo algorithm) were shown.
Results. A total of 158 patients were included in the study. The prevalence of visits to the ED due to NOM was 35.0 % (55 patients) and ADR was 5.1 % (8 patients). Overall, 88.0 % of the ADRs were considered avoidable and 74.0 % were of mild severity. On the other hand, 37.5 % (n=3) of suspected ADR were classified as avoidable and 50.0 % as probable. The multivariate logistic model indicates a possible association between NOMs with lower levels of schooling, the use of medicinal plants and the number of diseases.
Conclusions. The visit of 1 in 3 patients to the emergency department is associated with a NOM, while 1 in 20 is associated with an ADR. Further studies are needed.
Downloads
References
Baena MI, Faus MJ, Fajardo PC, et al. Medicine-related problems resulting in emergency department visits. Eur J Clin Pharmacol. 2006;62(5):387-393. doi:10.1007/s00228-006-0116-0
Schumock GT, Thornton JP. Focusing on the preventability of adverse drug reactions. Hosp Pharm. 1992;27(6):538.
Ruiz-Ramos J, Santolaya-Perrín R, García-Martín MªÁ, Sempere-Serrano P, Alonso-Díaz M, Calderón-Hernanz B. Prevalence of adverse drug events in emergency departments. FARM-URG multi-center project. Farm Hosp. 2021;45(4):176-179. doi:10.7399/fh.11596
Al-Arifi M, Abu-Hashem H, Al-Meziny M, Said R, Aljadhey H. Emergency department visits and admissions due to drug related problems at Riyadh military hospital (RMH), Saudi Arabia. Saudi Pharm J. 2014;22(1):17-25. doi:10.1016/j.jsps.2013.01.0015.
Haag JD, Bellamkonda VR, Perinpam L, et al. Prevalence and Categorization of Drug-Related Problems in the Emergency Department. J Emerg Med. 2022;63(2):192-199. doi:10.1016/j.jemermed.2022.04.016
Park S, Kim AJ, Ah YM, et al. Prevalence and predictors of medication-related emergency department visit in older adults: A multicenter study linking national claim database and hospital medical records. Front Pharmacol. 2022;13:1009485. doi:10.3389/fphar.2022.1009485
Ing Lorenzini K, Wainstein L, Spechbach H, et al. Opioid-related adverse drug reactions in patients visiting the emergency division of a tertiary hospital. Pharmacol Res Perspect. 2022;10(6):e01033. doi:10.1002/prp2.1033
Wallace E, McDowell R, Bennett K, Fahey T, Smith SM. Impact of Potentially Inappropriate Prescribing on Adverse Drug Events, Health Related Quality of Life and Emergency Hospital Attendance in Older People Attending General Practice: A Prospective Cohort Study. J Gerontol A Biol Sci Med Sci. 2017;72(2):271-277. doi:10.1093/gerona/glw140
Ayalew MB, Tegegn HG, Abdela OA. Drug Related Hospital Admissions; A Systematic Review of the Recent Literatures. Bull Emerg Trauma. 2019;7(4):339-346. doi:10.29252/beat-070401
Ramos-Linares S, Díaz-Ruiz P, Mesa-Fumero J et al. Incidencia de resultados negativos de medicación en un servicio de urgencias hospitalario y factores asociados. Farm Hosp. 2010;34(6):271-278. doi: 10.1016/j.farma.2010.01.009
Faus-Dáder, MJ, Amariles-Muñoz, P, Martínez-Martínez, F. Atención Farmacéutica. Servicios farmacéuticos orientados al paciente. 2nd ed. Granada: Técnica Avicam; 2022.
Unfried Segura E. Reacciones adversas a medicamentos como causa de consulta en el servicio de emergencias del Hospital San Juan de Dios. Revista Médica de la Universidad de Costa Rica. 2008;2(2):39-50.
González Argüello R. Farmacovigilancia en Costa Rica; la percepción del personal médico. Revista Médica de la Universidad de Costa Rica. 2007;1(1):52-62.
Castro I, Guardiola JM, Tuneu L, Sala ML, Faus MJ, Mangues MA. Drug-related visits to the emergency department in a Spanish university hospital. Int J Clin Pharm. 2013; 35(5):727-35. doi: 10.1007/s11096-013-9795-7
Queneau P, Bannwarth B, Carpentier F et al. Emergency department visits caused by adverse drug events: Results of a French survey. Drug Saf. 2007;30(1):81-88. doi: 10.2165/00002018-200730010-00008
Baena MI, Calleja MA, Romero JM, et al. Validación de un cuestionario para la identificación de problemas relacionados con los medicamentos en usuarios de un servicio de urgencias hospitalario. Ars Pharm. 2001;42(3-4):147-169.
Wingard DL, Berkman LF, Brand RJ. A multivariate analysis of health-related practices: A nine-year mortality follow-up of the Alameda county study. Am J Epidemiol. 1982;116(5):765-75. doi: 10.1093/oxfordjournals.aje.a113466
Baena MI, Marín R, Martínez-Olmos J, Fajardo P, Vargas J, Faus MJ. Nuevos criterios para determinar la evitabilidad de los problemas relacionados con los medicamentos. una revisión actualizada a partir de la experiencia con 2558 personas. Pharm care Esp. 2002;4:393-396.
Schneider PJ, Gift MG, Lee YP, Rothermich EA, Sill BE. Cost of medication-related problems at a university hospital. Am J Health Syst Pharm. 1995; 52(21):2415-2418. doi: 10.1093/ajhp/52.21.2415
Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239-245. doi: 10.1038/clpt.1981.154
García V, Marquina I, Olabarri A, Miranda G, Rubiera G, Baena MI. Resultados negativos asociados con la medicación en un servicio de urgencias hospitalario. Farm Hosp. 2008;32(3):157-162. doi: 10.1016/S1130-6343(08)72834-4
Barros da Silva W, Medeiros Netto AdS, Barcelos de Melo F. Frecuencia de problemas relacionados con los medicamentos en pacientes que visitaron el servicio de urgencia de un hospital regional. Seguimiento Farmacoterapéutico. 2005;3(4):213-224.
Baena MI. Problemas relacionados con los medicamentos como causa de consulta en el servicio de urgencias del Hospital Universitario Virgen de las Nieves de Granada [Tesis Doctoral]. Universidad de Granada; 2003.
Shahid R, Shoker M, Chu LM, Frehlick R, Ward H, Pahwa P. Impact of low health literacy on patients’ health outcomes: a multicenter cohort study. BMC Health Serv Res. 2022;22(1):1148. doi:10.1186/s12913-022-08527-9
Zorzela L, Khamba B, Sparks E, et al. Study of Natural Products Adverse Reactions (SONAR) in Adults with Mental Health Conditions: A Cross-Sectional Study. Drug Saf. 2021;44(9):999-1006. doi:10.1007/s40264-021-01092-w
Oscanoa TJ, Lizaraso F, Carvajal A. Hospital admissions due to adverse drug reactions in the elderly. A meta-analysis. Eur J Clin Pharmacol. 2017;73(6):759-770. doi:10.1007/s00228-017-2225-3
Dormann H, Muth-Selbach U, Krebs S, et al. Incidence and costs of adverse drug reactions during hospitalisation: computerised monitoring versus stimulated spontaneous reporting. Drug Saf. 2000;22(2):161-168. doi:10.2165/00002018-200022020-00007
Perrone V, Conti V, Venegoni M, et al. Seriousness, preventability, and burden impact of reported adverse drug reactions in Lombardy emergency departments: a retrospective 2-year characterization. Clinicoecon Outcomes Res. 2014;6:505-514. doi:10.2147/CEOR.S71301
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Carlos Esteban Quirós-Salas, Alfonso Pereira-Céspedes
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The articles, which are published in this journal, are subject to the following terms in relation to the rights of patrimonial or exploitation:
- The authors will keep their copyright and guarantee to the journal the right of first publication of their work, which will be distributed with a Creative Commons BY-NC-SA 4.0 license that allows third parties to reuse the work whenever its author, quote the original source and do not make commercial use of it.
b. The authors may adopt other non-exclusive licensing agreements for the distribution of the published version of the work (e.g., deposit it in an institutional telematic file or publish it in a monographic volume) provided that the original source of its publication is indicated.
c. Authors are allowed and advised to disseminate their work through the Internet (e.g. in institutional repositories or on their website) before and during the submission process, which can produce interesting exchanges and increase citations of the published work. (See The effect of open access).
